Skip to main content
Future Journal of Pharmaceutical Sciences

Table 7 Intermediate precision results

From: A new validated stability-indicating RP-HPLC method for simultaneous quantification of dolutegravir and lamivudine in bulk and pharmaceutical dosage form

Sample preparations

% assay

Lamivudine

Dolutegravir

Sample-1

98.9

99.2

Sample-2

100.1

100.0

Sample-3

99.4

99.6

Sample-4

100.2

98.9

Sample-5

99.7

100.1

Sample-6

100.4

99.9

AVG

99.8

99.6

S.D

0.56

0.48

%RSD

0.6

0.5

Back to article page